The End of an Era: Withdrawal of Xiapex (Clostridium histolyticum Collagenase) from the European Market
Eur Urol
.
2020 May;77(5):660-661.
doi: 10.1016/j.eururo.2019.11.019.
Epub 2019 Dec 4.
Authors
Andrea Cocci
1
,
Giorgio Ivan Russo
2
,
Juan Ignacio Martinez Salamanca
3
,
David Ralph
4
,
Alessandro Palmieri
5
,
Nicola Mondaini
6
Affiliations
1
Department of Urology, University of Florence, Florence, Italy. Electronic address: cocci.andrea@gmail.com.
2
Urology Section, University of Catania, Catania, Italy.
3
Department of Urology, Hospital Universitario Puerta De Hierro-Majadahonda, Madrid, Spain.
4
University College London Hospitals & St Peter's Andrology, London, UK.
5
Department of Urology, University of Naples Federico II, Naples, Italy.
6
Villa Donatello Private Hospital, Florence, Italy.
PMID:
31810821
DOI:
10.1016/j.eururo.2019.11.019
No abstract available
Publication types
Letter
MeSH terms
Collagenases / supply & distribution*
Collagenases / therapeutic use
European Union
Humans
Male
Penile Induration / drug therapy
Substances
Collagenases
xiapex